PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 203 filers reported holding PDL BIOPHARMA INC in Q2 2015. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,820,000 | +69.3% | 258,702 | +85.5% | 0.04% | -57.9% |
| Q4 2014 | $1,075,000 | -75.8% | 139,465 | -76.5% | 0.11% | -7.8% |
| Q3 2014 | $4,433,000 | +147.9% | 593,499 | +175.8% | 0.12% | +169.8% |
| Q1 2014 | $1,788,000 | -44.2% | 215,206 | -46.4% | 0.04% | -50.6% |
| Q3 2013 | $3,202,000 | +2271.9% | 401,814 | +2196.1% | 0.09% | +2800.0% |
| Q2 2013 | $135,000 | – | 17,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |